Cited by 69Inflammatory Bowel DiseaseTryptophan and brain disordersOcular Diseases and Behçet’s Syndrome

Systematic review with meta-analysis: the impact of a depressive state on disease course in adult inflammatory bowel disease

Open access
Alexakis, C., Kumar, S., Saxena, S., Pollok, R.·2017·Alimentary Pharmacology & Therapeutics

Abstract

BACKGROUND: Despite a higher prevalence of psychosocial morbidity in Inflammatory Bowel Disease (IBD), the association between depressive state and disease course in IBD is poorly understood. AIM: To investigate the impact of depressive state on disease course in IBD. METHODS: We conducted a systematic review in MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews and PsychINFO for prospective studies evaluating the impact of baseline depressive state on subsequent disease course in adult IBD. RESULTS: Eleven studies matched our entry criteria, representing 3194 patients with IBD. Three reported on patients with ulcerative colitis (UC), four included patients with Crohn's disease (CD) exclusively, and four studies included both UC and CD. Five studies reported an association between depressive state and disease course. None of the UC-specific studies found any association. In three of four CD-specific studies, a relationship between depressive state and worsening disease course was found. In four of five studies including patients in remission at baseline, no association between depressive state and disease course was found. Pooled analysis of IBD studies with patients in clinical remission at baseline identified no association between depressive state and disease course (HR 1.04, 95%CI: 0.97-1.12). CONCLUSION: There is limited evidence to support an association between depressive state and subsequent deterioration in disease course in IBD, but what data that exist are more supportive of an association with CD than UC. Baseline disease activity may be an important factor in this relationship. Further studies are needed to understand the relationship between mental health and outcomes in IBD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.14171

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. North CS, Alpers DH, Helzer JE, Spitznagel EL, Clouse RE. Do life events or depression exacerbate inflammatory bowel disease. Ann Intern Med. 1991;114:381-386.
  2. Mikocka-Walus A, Turnbull DA, Moulding NT, Wilson IG, Andrews JM, Holtmann GJ. Antidepressant and inflammatory bowel disease: a systematic review. Clin Pract Epidemiol Ment Heal. 2006;2(15):1-8. doi:10.1186/1745-0179-2-Received. · DOI

Cited by

Sorted by citations

Authors
Alexakis, C., Kumar, S., Saxena, S., & Pollok, R.
Affiliations
  • St George’s University Hospitals NHS Foundation Trust (GB)
  • Imperial College London (GB)
Corresponding author
Pollok, R.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2017-06-02
Volume
46
Issue
3
Pages
225-235
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2620927568
Cited by
69
References
61
Citations by year
2026: 4 · 2025: 3 · 2024: 9 · 2023: 11 · 2022: 10 · 2021: 12 · 2020: 6 · 2019: 7 · 2018: 5 · 2017: 2
FWCI
0.70
Type
journal article
Language
en
Open access
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Funders
National Institute for Health Research (CDF‐2011‐04‐048)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
inflammatory bowel disease, depressive state, depression, clinical course, Crohn's disease, ulcerative colitis, clinical remission, disease activity, mental health, psychosocial morbidity
MeSH terms
Adult, Colitis, Ulcerative, Crohn Disease, Depression, Humans, Prevalence, Databases, Factual, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review